Health Catalyst, Inc. (HCAT)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Total revenue | 80,721 | 76,353 | 75,902 | |
| Sales and marketing | 13,206 | 11,342 | 12,745 | |
| Research and development | 12,392 | 14,193 | 13,884 | |
| Goodwill impairment | 28,769 | - | - | |
| General and administrative | 8,284 | 12,209 | 14,363 | |
| Depreciation and amortization | 12,684 | 9,983 | 10,657 | |
| Total operating expenses | 75,335 | 47,727 | 51,649 | |
| Technology | 18,352 | - | - | |
| Professional Services | 24,128 | - | - | |
| Total cost of revenue, excluding depreciation and amortization | 42,480 | 42,313 | 40,060 | |
| Loss from operations | -37,094 | -13,687 | -15,807 | |
| Interest and other (expense) income, net | -3,803 | -1,514 | - | |
| Interest and other income, net | - | - | 2,361 | |
| Loss before income taxes | -40,897 | -15,201 | -13,446 | |
| Income tax provision | 81 | -475 | 70 | |
| Net loss | -40,978 | -14,726 | -13,516 | |
| Net loss per share, basic (in usd per share) | -0.59 | -0.24 | -0.23 | |
| Net loss per share, diluted (in usd per share) | -0.59 | -0.24 | -0.23 | |
| Weighted-average shares outstanding used in calculating net loss per share, basic (in shares) | 69,625,540 | 60,441,000 | 59,304,000 | |
| Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares) | 69,625,540 | 60,441,000 | 59,304,000 | |